Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP study according EU/OECD guideline.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
3',4'-dichloro-5-fluoro-[1,1'-biphenyl]-2-amine
EC Number:
700-287-9
Cas Number:
877179-04-9
Molecular formula:
C12H8Cl2FN
IUPAC Name:
3',4'-dichloro-5-fluoro-[1,1'-biphenyl]-2-amine

In vivo test system

Test animals

Species:
mouse
Strain:
NMRI
Sex:
female

Study design: in vivo (LLNA)

Vehicle:
acetone/olive oil (4:1 v/v)
Concentration:
0, 3, 10 and 30%.
No. of animals per dose:
6 mice per group

Results and discussion

In vivo (LLNA)

Results
Parameter:
SI
Remarks on result:
other: The NMRI mice did not show an increase in the stimulation indices for cell counts or for weights of the draining lymph nodes after application of the test substance.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information Criteria used for interpretation of results: EU
Executive summary:

A LLNA/IMDS was carried out in female NMRI mice after epicutaneous application of a formulation containing 0%, 3%, 10% or 30% of the test substance for 3 consecutive days onto both ears of the animals.

This study does neither point to a non-specific (irritant) nor to a specific immunostimulating (sensitizing) potential of the test item.

This applies to NMRI mice, for weight and cell counts of the draining lymph nodes as well as ear swelling and ear weight indices evaluated after application of the test substance.

Taken together, no antigen specific activation of the cells of the immune system via dermal route was determined after application of up to and including 30%the test substanceby the method used. Therefore, the concentration of 30% turned out to be the NOEL for the parameters investigated in this study with respect to skin sensitization.